American Healthcare REIT, Inc. (NYSE:AHR - Get Free Report) has been given an average rating of "Buy" by the eleven ratings firms that are presently covering the company, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $41.8889.
Several equities analysts have recently commented on the company. Morgan Stanley restated an "overweight" rating on shares of American Healthcare REIT in a research note on Wednesday, September 3rd. Scotiabank restated an "outperform" rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Robert W. Baird assumed coverage on American Healthcare REIT in a research note on Friday, July 18th. They set an "outperform" rating and a $41.00 price target on the stock. JMP Securities raised their price target on American Healthcare REIT from $40.00 to $45.00 and gave the company a "market outperform" rating in a research note on Monday, August 11th. Finally, Baird R W upgraded American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th.
Check Out Our Latest Report on American Healthcare REIT
Insider Activity
In other American Healthcare REIT news, CIO Stefan K.L. Oh sold 3,860 shares of American Healthcare REIT stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the transaction, the executive owned 95,671 shares in the company, valued at $3,453,723.10. The trade was a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the transaction, the executive vice president owned 59,100 shares in the company, valued at $2,475,699. This trade represents a 6.12% decrease in their position. The disclosure for this sale can be found here. 1.00% of the stock is owned by insiders.
Hedge Funds Weigh In On American Healthcare REIT
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wolff Wiese Magana LLC purchased a new position in American Healthcare REIT in the first quarter valued at about $25,000. Darwin Wealth Management LLC purchased a new stake in shares of American Healthcare REIT during the second quarter worth about $31,000. Total Investment Management Inc. purchased a new stake in shares of American Healthcare REIT during the second quarter worth about $32,000. Physician Wealth Advisors Inc. purchased a new stake in shares of American Healthcare REIT during the second quarter worth about $34,000. Finally, MassMutual Private Wealth & Trust FSB grew its stake in shares of American Healthcare REIT by 189.0% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock worth $29,000 after acquiring an additional 633 shares during the last quarter. Hedge funds and other institutional investors own 16.68% of the company's stock.
American Healthcare REIT Trading Up 1.1%
Shares of NYSE:AHR traded up $0.46 on Friday, hitting $43.39. 458,583 shares of the company's stock were exchanged, compared to its average volume of 1,623,889. American Healthcare REIT has a 12 month low of $22.55 and a 12 month high of $43.52. The stock has a market capitalization of $7.31 billion, a price-to-earnings ratio of -197.34, a price-to-earnings-growth ratio of 2.20 and a beta of 1.09. The business's 50 day simple moving average is $39.62 and its two-hundred day simple moving average is $34.75. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.48 and a quick ratio of 0.48.
American Healthcare REIT (NYSE:AHR - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The business had revenue of $542.50 million during the quarter, compared to the consensus estimate of $539.49 million. During the same period last year, the company earned $0.33 earnings per share. The business's revenue for the quarter was up 7.5% compared to the same quarter last year. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Analysts anticipate that American Healthcare REIT will post 1.41 EPS for the current fiscal year.
American Healthcare REIT Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.3%. The ex-dividend date was Monday, June 30th. American Healthcare REIT's payout ratio is -454.55%.
American Healthcare REIT Company Profile
(
Get Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Articles

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.